Bhoja Ravi, Ryan Matthew W, Klein Kevin, Minhajuddin Abu, Melikman Emily, Hamza Mohamed, Marple Bradley F, McDonagh David L
Department of Anesthesiology and Pain Management The University of Texas Southwestern Dallas Texas USA.
Department of Otolaryngology The University of Texas Southwestern Dallas Texas USA.
Laryngoscope Investig Otolaryngol. 2020 Apr 16;5(3):348-353. doi: 10.1002/lio2.375. eCollection 2020 Jun.
Multimodal perioperative analgesia including acetaminophen is recommended by current guidelines. The comparative efficacy of intravenous vs oral acetaminophen in sinus surgery is unknown. We aimed to determine whether intravenous or oral acetaminophen results in superior postoperative analgesia following sinus surgery.
This was a prospective randomized trial with blinded endpoint assessments conducted at a single large academic medical center. Subjects undergoing functional endoscopic sinus surgery were randomized to intravenous vs oral acetaminophen in addition to standard anesthetic and surgical care. The primary outcome was visual analogue scale pain score at 1 hour postoperatively.
One hundred and ten adult patients were randomized; 9 were excluded from the data analysis. Fifty patients were assigned to intravenous acetaminophen and 51 to oral acetaminophen. Postoperative pain scores at 1 hour (primary endpoint) were not significantly different between the intravenous and oral acetaminophen groups. Similarly, there was no significant difference in pain scores at 24 hours postoperatively. Finally, there was no significant difference in postoperative opioid usage in the postanesthesia care unit or over the first 24 hours postoperatively.
This is the first comparative efficacy trial of oral vs intravenous acetaminophen in sinus surgery. There was no significant difference in pain scores at 1 or 24 hours postoperatively, and no difference in postoperative opioid use. Intravenous acetaminophen offers no apparent advantage over oral acetaminophen in patients undergoing sinus surgery.
1b.
当前指南推荐采用包括对乙酰氨基酚在内的多模式围手术期镇痛。对乙酰氨基酚静脉给药与口服给药在鼻窦手术中的相对疗效尚不清楚。我们旨在确定静脉注射或口服对乙酰氨基酚在鼻窦手术后是否能带来更优的术后镇痛效果。
这是一项在单一大型学术医学中心进行的前瞻性随机试验,终点评估采用盲法。接受功能性内镜鼻窦手术的受试者在接受标准麻醉和手术护理的基础上,被随机分为静脉注射对乙酰氨基酚组和口服对乙酰氨基酚组。主要结局指标是术后1小时的视觉模拟评分法疼痛评分。
110例成年患者被随机分组;9例被排除在数据分析之外。50例患者被分配至静脉注射对乙酰氨基酚组,51例被分配至口服对乙酰氨基酚组。静脉注射对乙酰氨基酚组和口服对乙酰氨基酚组术后1小时(主要终点)的疼痛评分无显著差异。同样,术后24小时的疼痛评分也无显著差异。最后,麻醉后护理单元或术后头24小时内的术后阿片类药物使用量也无显著差异。
这是第一项关于口服与静脉注射对乙酰氨基酚在鼻窦手术中比较疗效的试验。术后1小时和24小时的疼痛评分无显著差异,术后阿片类药物使用量也无差异。在接受鼻窦手术的患者中,静脉注射对乙酰氨基酚相比口服对乙酰氨基酚没有明显优势。
1b。